ClinicalTrials.govpublic full text
Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients
stage ii colon cancer, stage iii colon cancer, her2-positive colon cancer, ras wild-type colon cancer, circulating tumor dna, folfox, capox, folfoxiri, trifluridine/tipiracil, trastuzumab, tucatinib, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 804968
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.